Abstract

Protease-activated receptors (PARs) belong to the G protein-coupled receptor (GPCR) family. Compared to other GPCRs, the specificity of the four PARs is the lack of physiologically soluble ligands able to induce their activation. Indeed, PARs are physiologically activated after proteolytic cleavage of their N-terminal domain by proteases. The resulting N-terminal end becomes a tethered activation ligand that interact with the extracellular loop 2 domain and thus induce PAR signal. PARs expression is ubiquitous and these receptors have been largely described in chronic inflammatory diseases and cancer. In this review, after describing their discovery, structure, mechanisms of activation, we then focus on the roles of PARs in the intestine and the two main diseases affecting the organ, namely inflammatory bowel diseases and cancer.

Highlights

  • Protease-activated receptors (PARs) belong to the family of G-protein coupled receptors (GPCRs)

  • Each receptor can be stimulated by an activator ligand—TFLLR for PAR1, SLIGKV for PAR2, TFRGAP for PAR3, and GYPGQV for PAR4—followed by an amino acid sequence involved in the inhibition of its self-activation [21]

  • The authors demonstrated that MMP1 activates PAR1 via an activator ligand located two amino acids upstream of the one generated by thrombin (PRSFLLR ligand), but resulting in the same signaling as the one induced by thrombin

Read more

Summary

Frontiers in Endocrinology

Protease-activated receptors (PARs) belong to the G protein-coupled receptor (GPCR) family. Compared to other GPCRs, the specificity of the four PARs is the lack of physiologically soluble ligands able to induce their activation. PARs are physiologically activated after proteolytic cleavage of their N-terminal domain by proteases. The resulting N-terminal end becomes a tethered activation ligand that interact with the extracellular loop 2 domain and induce PAR signal. PARs expression is ubiquitous and these receptors have been largely described in chronic inflammatory diseases and cancer. After describing their discovery, structure, mechanisms of activation, we focus on the roles of PARs in the intestine and the two main diseases affecting the organ, namely inflammatory bowel diseases and cancer

INTRODUCTION
PARs in Intestinal Inflammation and Cancer
Mechanisms of Activation
Sites of expression in the gut Activating proteases
Serine Proteases
Cysteine Proteases
PROTEASES ACTIVATING PARs
PARs AND INTESTINAL HOMEOSTASIS
Intestinal Secretions and PARs
Intestinal Motility and PARs
Sensory Function
Intestinal Permeability
Survival and Proliferation
PARs IN INFLAMMATORY BOWEL DISEASES
PARs in IBD
PARs IN COLORECTAL CANCER
PARs in CRC
Findings
CONCLUSION AND FUTURES PERSPECTIVES
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.